Data Science in the News

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

June 7, 2022- 
The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

Kevin McLoughlin applies computational biology to complex problems

May 17, 2022- 
Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Accelerating the path to precision medicine

March 22, 2022- 
LLNL joined the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) consortium in 2018. The national, multiyear, multidisciplinary effort, led by the University of California at San Francisco in collaboration with Lawrence Berkeley and Argonne national laboratories and other leading research organizations and universities, combines neuroimaging, blood-based...

Machine learning model finds COVID-19 risks for cancer patients

March 10, 2022- 
A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

LLNL team models COVID-19 disease progression and identifies risk factors

Feb. 15, 2022- 
An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

COVID-19 R&D: Computing responds to pandemic

Jan. 19, 2022- 
When the COVID-19 pandemic began, the Laboratory immediately started seeking solutions to the myriad challenges posed by the global crisis. The Computing Directorate jumped right in with research and development activities that combine molecular screening to inform antiviral drug experimentation; a generative molecular design software platform to optimize properties of antiviral drugs; an...

Unprecedented multiscale model of protein behavior linked to cancer-causing mutations

Jan. 10, 2022- 
LLNL researchers and a multi-institutional team have developed a highly detailed, machine learning–backed multiscale model revealing the importance of lipids to the signaling dynamics of RAS, a family of proteins whose mutations are linked to numerous cancers. Published by the Proceedings of the National Academy of Sciences, the paper details the methodology behind the Multiscale Machine...

Digital twins for cancer patients could be ‘paradigm shift’ for predictive oncology

Dec. 16, 2021- 
A multi-institutional team, including an LLNL contributor, has proposed a framework for digital twin models of cancer patients that researchers say would create a “paradigm shift” for predictive oncology. Published online Nature Medicine on November 25, the proposed framework for Cancer Patient Digital Twins (CPDTs) — virtual representations of cancer patients using real-time data — would...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

Oct. 21, 2021- 
LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Tackling the COVID-19 pandemic

Oct. 11, 2021- 
To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Inaugural industry forum inspires ML community

Sept. 16, 2021- 
LLNL held its first-ever Machine Learning for Industry Forum (ML4I) on August 10–12. Co-hosted by the Lab’s High-Performance Computing Innovation Center (HPCIC) and Data Science Institute (DSI), the virtual event brought together more than 500 enrollees from the Department of Energy (DOE) complex, commercial companies, professional societies, and academia. Industry sponsors included...

60 years of cancer research

Sept. 10, 2021- 
From studying radioactive isotope effects to better understanding cancer metastasis, the Laboratory’s relationship with cancer research endures some 60 years after it began, with historical precedent underpinning exciting new research areas. In one Cancer Moonshot project, research includes a close synergy between experiments and computation, allowing scientists to get a better picture of the...

LLNL, NNSA and elected officials celebrate opening of Livermore Valley Open Campus expansion

Aug. 26, 2021- 
Leaders from the NNSA, Congressional representatives and local elected officials gathered at LLNL on August 10 to celebrate an expansion to the Livermore Valley Open Campus (LVOC). The Lab hosted a ribbon-cutting ceremony for a new office building (Bldg. 642) and a conference annex (Bldg. 643), which will provide modern office and meeting space for LLNL researchers in predictive biology...

LLNL/ATOM engagement with Purdue introduces students to drug design modeling

Aug. 9, 2021- 
Through an engagement with Purdue University’s The Data Mine learning community, LLNL and Purdue are partnering to speed up drug design using computational tools under the Accelerating Therapeutic Opportunities in Medicine (ATOM) project. Over two recent semesters (fall 2020 and spring 2021), LLNL bioinformatics scientist and ATOM researcher Jonathan Allen mentored a cohort of 20...

Brian Gallagher combines science with service

June 20, 2021- 
Brian Gallagher works on applications of machine learning for a variety of science and national security questions. He’s also a group leader, student mentor, and the new director of LLNL’s Data Science Challenge. The Lab has enabled Gallagher to combine scientific pursuits with leadership positions and people-focused responsibilities. “For a long time, my primary motivation was learning new...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

June 7, 2021- 
LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Advanced Data Analytics for Proliferation Detection shares technical advances during two-day meeting

May 7, 2021- 
The Advanced Data Analytics for Proliferation Detection (ADAPD) program held a two-day virtual technical exchange meeting recently. The goal of the meeting was to highlight the science-based and data-driven analysis work conducted by ADAPD to advance the state-of-the-art to accelerate artificial intelligence (AI) innovation and develop AI-enabled systems to enhance the United States’...

COVID-19 HPC Consortium reflects on past year

April 1, 2021- 
COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

ATOM Consortium welcomes 3 DOE national labs to accelerate drug discovery

March 29, 2021- 
The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, of which LLNL is part, announced the U.S. Department of Energy’s Argonne, Brookhaven and Oak Ridge national laboratories are joining the consortium to further develop ATOM’s AI-driven drug discovery platform. The public-private ATOM consortium aims to transform drug discovery from a slow, sequential and high-risk...

'Self-trained' deep learning to improve disease diagnosis

March 4, 2021- 
New work by computer scientists at LLNL and IBM Research on deep learning models to accurately diagnose diseases from X-ray images with less labeled data won the Best Paper award for Computer-Aided Diagnosis at the SPIE Medical Imaging Conference on February 19. The technique, which includes novel regularization and “self-training” strategies, addresses some well-known challenges in the...